Hsbc Global Res Upgrades Haleon (NYSE:HLN) to “Strong-Buy”

Haleon (NYSE:HLN) was upgraded by Hsbc Global Res from a “hold” rating to a “strong-buy” rating in a note issued to investors on Wednesday,Zacks.com reports.

HLN has been the topic of a number of other research reports. Weiss Ratings reiterated a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. Jefferies Financial Group reiterated a “buy” rating on shares of Haleon in a research note on Tuesday. Morgan Stanley restated an “overweight” rating on shares of Haleon in a report on Monday, December 15th. Finally, Deutsche Bank Aktiengesellschaft lowered shares of Haleon from a “hold” rating to a “sell” rating in a research note on Monday, January 12th. One analyst has rated the stock with a Strong Buy rating, four have given a Buy rating, three have given a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat, Haleon currently has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Trading Up 1.1%

NYSE HLN opened at $10.24 on Wednesday. The stock has a market cap of $45.60 billion, a P/E ratio of 26.26 and a beta of 0.19. The company’s fifty day simple moving average is $9.83 and its 200-day simple moving average is $9.60. The company has a current ratio of 0.87, a quick ratio of 0.63 and a debt-to-equity ratio of 0.48. Haleon has a 52 week low of $8.71 and a 52 week high of $11.42.

Institutional Trading of Haleon

A number of large investors have recently modified their holdings of the company. Brighton Jones LLC bought a new stake in Haleon during the 4th quarter valued at $187,000. AQR Capital Management LLC boosted its holdings in Haleon by 22.5% during the first quarter. AQR Capital Management LLC now owns 96,323 shares of the company’s stock worth $991,000 after buying an additional 17,720 shares in the last quarter. Focus Partners Wealth grew its holdings in shares of Haleon by 7.6% in the 1st quarter. Focus Partners Wealth now owns 73,106 shares of the company’s stock worth $752,000 after acquiring an additional 5,178 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in shares of Haleon by 33.0% in the 1st quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock valued at $50,000 after purchasing an additional 1,203 shares during the period. Finally, Wealth Enhancement Advisory Services LLC lifted its stake in Haleon by 10.8% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 104,940 shares of the company’s stock valued at $1,076,000 after buying an additional 10,192 shares in the last quarter. Institutional investors and hedge funds own 6.67% of the company’s stock.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over?the?counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self?care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.